Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3351 results

Sort By:

RCT: The Effect of an Electronic Clinical Decision Support Application on Perioperative Medication Errors.

Study ID: NCT04342013
Start Date: 2027-01
End Date: 2027-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment

Electronic Clinical Decision Support Application

Sponsor

Karen C. Nanji,M.D.,M.P.H.

Source: clinicaltrials.gov

Share:
Add to list

Trial of Routine Abdominal Wall Closure Versus Reinforcement With TIGR Matrix Onlay

Study ID: NCT02487134
Start Date: 2026-01-01
End Date: 2027-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

TIGR Matrix

Control

Sponsor

Karolinska Institutet

Source: clinicaltrials.gov

Share:
Add to list

FT836 CAR T-cell Therapy in Combination With Daratumumab in Patients With Relapsed and/or Refractory Multiple Myeloma

Study ID: NCT07221032
Start Date: 2026-03
End Date: 2030-03
Study Type

Interventional

Study Phase

Phase1

No. of Participants

12

Intervention / Treatment

FT836 CAR T cells (1 x 10^8 cells per dose)

FT836 CAR T cells (3 x 108 cells per dose)

FT836 CAR T cells (up to 9 x 108 cells per dose)

Daratumumab 16 mg/kg

Sponsor

Medical College of Wisconsin

Source: clinicaltrials.gov

Share:
Add to list

Clinically Important or Just Statistically Significant? MCID for DVISS and PIN-Q in Children With UI

Study ID: NCT07242898
Start Date: 2026-09-01
End Date: 2026-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Standard Urotherapy (SU)

Sponsor

Artvin Coruh University

Source: clinicaltrials.gov

Share:
Add to list

Diclofenac for Prevention of Post-ERC Pancreatitis

Study ID: NCT03595150
Start Date: 2026-01-01
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

1000

Intervention / Treatment

Diclofenac

Sponsor

Karolinska Institutet

Source: clinicaltrials.gov

Share:
Add to list

ADO-5030 in Bronchoconstriction Challenge, Phase 1b

Study ID: NCT07281274
Start Date: 2026-01-01
End Date: 2026-07-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

36

Intervention / Treatment

ADO-5030

Sponsor

Adversity

Source: clinicaltrials.gov

Share:
Add to list

Testing the SurVaxM Vaccine for Lung Cancer Prevention

Study ID: NCT07169617
Start Date: 2026-02-25
End Date: 2027-09-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

80

Intervention / Treatment

Biospecimen Collection

Montanide ISA 51 VG

Administration Questionnaire

Sargramostim

SVN53-67/M57-KLH Peptide Vaccine

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma

Study ID: NCT07281417
Start Date: 2026-02-27
End Date: 2033-10-03
Study Type

Interventional

Study Phase

Phase2

No. of Participants

108

Intervention / Treatment

Biopsy Procedure

Biospecimen Collection

Carboplatin

Carboplatin

Cemiplimab

Chemoradiotherapy

Cisplatin

Computed Tomography

Magnetic Resonance Imaging

Paclitaxel

Positron Emission Tomography

Radiation Therapy

Surgical Procedure

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Examining Nurses' Trust and Acceptance of FAIR, an AI-powered Falls Risk Recommender

Study ID: NCT07078240
Start Date: 2027-01-01
End Date: 2029-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Falls risk - Artificial Intelligence Recommender (FAIR)

modified Western Health Falls Risk Assessment Tool (mWHeFRA)

Sponsor

Tan Tock Seng Hospital

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of a Dietary Supplement Containing Melissa Officinalis Formulated in Phospholipids on Mood Well-being and Cortisol Modulation

Study ID: NCT06942897
Start Date: 2026-06-15
End Date: 2026-09-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Melissa officinalis supplement

Sponsor

Pavia Personal Services Company

Source: clinicaltrials.gov

Share:
Add to list